Tyra Biosciences (TYRA) Change in Acquisitions & Divestments (2024 - 2026)

Tyra Biosciences' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $42.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 8.07% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $177.0 million (up 1.26% YoY) and the FY2025 annual result came in at $173.9 million, up 4.81% from the prior year.
• Change in Acquisitions & Divestments was $42.0 million for Q1 2026 at Tyra Biosciences, down from $43.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $58.0 million in Q3 2024 and bottomed at $30.0 million in Q1 2024.
• A 3-year average of $42.4 million and a median of $42.0 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
• Peak annual rise in Change in Acquisitions & Divestments reached 29.7% in 2025, while the deepest fall reached 13.09% in 2025.
• Tyra Biosciences' Change in Acquisitions & Divestments stood at $45.0 million in 2024, then retreated by 3.24% to $43.5 million in 2025, then dropped by 3.42% to $42.0 million in 2026.
• Business Quant data shows TYRA's Change in Acquisitions & Divestments at $42.0 million in Q1 2026, $43.5 million in Q4 2025, and $50.4 million in Q3 2025.